Heart Information Network http://www.heartinfo.org/
Heart and Stroke Foundation of Canada http://ww2.heartandstroke.ca/
Health Heart.org http://www.health-heart.org/
Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Chan KA, Andrade SE, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A
reductase and risk of fracture among older women.
Jick H, Zomberg GL, Jick SS, et al. Statins and the risk of dementia.
Ichihara A, Hayashi M, Ryuzaki M, et al. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus.
Nephrol Dial Transplant.
Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria.
Ann Intern Med.
DynaMed Editorial Team. Coronary artery disease (CAD). EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/. Updated March 29, 2011. Accessed April 19, 2011.
DynaMed Editorial Team. Statins: overview. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/. Updated March 29, 2011. Accessed April 19, 2011.
DynaMed Editorial Team. Statins and cancer risk: overview. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/. Updated June 18, 2010. Accessed April 19, 2011.
DynaMed Editorial Team. Statins for prevention of cardiovascular disease: overview. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/. Updated March 25, 2011. Accessed April 19, 2011.
Kshirsagar AV, Shoham DA, Bang H, et al. The effect of cholesterol reduction with cholestyramine on renal function.
Am J Kidney Dis.
Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study.
Int J Cancer.
Graaf MR, Beiderbeck AB, Egberts AC, et al. The risk of cancer in users of statins.
J Clin Oncol.
Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy: a case-control study.
Wegman S, deVries F, Leufkens B, et al. Use of statins and risk of fractures.
Wolozin B, Kellman W, Rousseau P, et al. Decreased prevalence of Alzheimer's disease
associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
1/30/2009 DynaMed's Systematic Literature Surveillance
: Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
J Am Coll Cardiol.
3/6/2012 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php: FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. Published February 28, 2012. Accessed March 6, 2012.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.